LGC reports half year trading in line with expectations
Update for the half year ended 30 September 2021
Read MoreTo contact the press office please email or call +44 7408 850 514
Update for the half year ended 30 September 2021
Read MoreSite will be dedicated to medium to large scale and early to late Phase Clinical GMP manufacturing of Nucleic Acid Therapeutics
Read MoreSite will be dedicated to medium to large scale and early to late Phase Clinical GMP manufacturing of Nucleic Acid Therapeutics
Read MoreLGC is committing to being carbon net zero by 2050
Read MoreLGC’s MHRA Laboratories Team supports the annual BP publication by providing physico-chemical analysis of substances
Read MoreNexar workflow continues to enable simple, scalable, and cost-effective testing.
Read MoreLGC’s validated technology provides gold-standard sensitivity and specificity based on clinical data, as well as material cost and time savings.
Read MoreOn 14th October, we celebrate World Standards Day. Documentary standards provide an agreed “best way of doing things”, based on expert knowledge and best practice from across the world.
Read MoreNML team analysis vital to understanding potential discrepancies in measured viral burden used to manage CoVid-19 pandemic.
Read MoreMark Dearden recently spoke with GenomeWeb to discuss CoVid workflow and much more besides
Read MoreEuan succeeds Tim Robinson, who will become Chairman of LGC
Read MoreIn support of advancing innovation in measurement research, a centre focussed on advanced measurement research and health translation was launched in Glasgow in December 2019, as an articulation of a strategic continuing partnership between the UK National Measurement Laboratory (NML) hosted at LGC and the University of Strathclyde.
Read More